Vimarsana
Biggest News Aggregation in the World

Page 19 - Robertg Kramer News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Robertg Kramer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Robertg Kramer Today - Breaking & Trending Today

Vaccine maker's CEO sold millions in stock before J&J doses were ruined: report - Vimarsana News

Vaccine maker's CEO sold millions in stock before J&J doses were ruined: report

The president and CEO of Emergent BioSolutions sold off more than $10 million worth of his company's stock shortly before millions of doses of the Johnson & Johnson COVID-19 vaccine were ruined at a Baltimo

EBS CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc. - Vimarsana News

EBS CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc.

Share this article Share this article RADNOR, Pa., April 21, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed in the United States District Court for the District of Maryland against Emergent BioSolutions Inc. (NYSE: EBS) ("Emergent") on behalf of those who purchased or acquired Emergent common stock between July 6, 2020 and March 31, 2021, inclusive (the "Class Period"). Deadline Reminder:  Investors who purchased or acquired Emergent common stock during the Class Period may, no later than June ...

Congressional Investigation Launched Into Emergent BioSolutions' Federal Vaccine Contracts - Vimarsana News

Congressional Investigation Launched Into Emergent BioSolutions' Federal Vaccine Contracts

Congressional investigators have requested top executives from Emergent BioSolutions testify before the Select Subcommittee.

Source: nbcdfw.com
Saxena White P.A. Files Securities Fraud Class Action Against Emergent BioSolutions Inc. - Vimarsana News

Saxena White P.A. Files Securities Fraud Class Action Against Emergent BioSolutions Inc.

Saxena White P.A. Files Securities Fraud Class Action Against Emergent BioSolutions Inc. April 19, 2021 12:39 ET | Source: Saxena White P.A. Saxena White P.A. Boca Raton, Florida, UNITED STATES BOCA RATON, Fla., April 19, 2021 (GLOBE NEWSWIRE) -- Saxena White P.A. has filed a securities fraud class action lawsuit (the “Class Action”) in the United States District Court for the District of Maryland against Emergent BioSolutions Inc. (“Emergent” or the “Company”) (NYSE: EBS) on behalf of all persons or entities who purchased or otherwise...

Emergent 'on track' with COVID-19 vaccine production obligations, J&J takes control of Baltimore plant - Vimarsana News

Emergent 'on track' with COVID-19 vaccine production obligations, J&J takes control of Baltimore plant

Emergent ‘on track’ with COVID-19 vaccine production obligations, J&J takes control of Baltimore plant Emergent BioSolutions Inc yesterday reported that is on target in terms of all its commitments for COVID-19 vaccine production; it also reaffirmed its financial guidance, after a production issue at its Baltimore plant last week saw a massive batch of Johnson & Johnson’s COVID-19 vaccine doses spoiled. The contract development and manufacturing organization (CDMO) has been producing both the J&J and AstraZeneca vaccines, but mixed up ingredients from the two...